PMPR and Chlorhexidine on Periodontal Disease and Vascular Function
Sponsored by Mahdi Mutahar
About this trial
Last updated a month ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 3 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Participants must have a minimum of 2 natural teeth in each sextant (at least 12 teeth overall).
* Individuals with clinically diagnosed gingivitis and/or early periodontitis (stage 1 and 2)
* Must not have undergone periodontal maintenance therapy (PMPR) within the last 6 months.
* Must not currently be wearing orthodontic appliances, due to their effect on oral microbiota and plaque composition.
* Must not be using removable orthodontic appliances, as they increase plaque accumulation.
* Must not have taken any antibiotic treatments within the last 3 months.
* Must be able to provide written informed consent.
* Individuals with dental erosion or caries will still be included but matched during the baseline visit.
Exclusion Criteria
* Individuals under regular medication within one month of the study start date for any medical condition (such as hypertension and/or diabetes)
* Pregnant or breastfeeding individuals.
* Individuals requiring an interpreter or who are non-English speakers.
* Individuals unable to provide written informed consent.
* Individuals participating in another ongoing clinical study (other than observational studies) within 3 months prior to or during this study.
* Individuals who have used mouthwash or tongue scrapers in the last 6 weeks.
* Individuals who consume 20 or more cigarettes per day.
* Individuals who consume more than 5 alcoholic drinks per day.
